Department of Endocrinology and Metabolic Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Department of Laboratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Hepatol Int. 2022 Oct;16(5):1085-1093. doi: 10.1007/s12072-022-10384-x. Epub 2022 Jul 13.
BACKGROUND/PURPOSE OF THE STUDY: Although low skeletal muscle mass is associated with non-alcoholic fatty liver disease (NAFLD), it is currently uncertain whether there are associations between weight-adjusted appendicular skeletal muscle (ASM%), severity of histological features of NAFLD, and the patatin-like phospholipase domain-containing 3 (PNPLA3) rs738409 polymorphism. Our aim was to test for a possible influence of the PNPLA3 rs738409 variant on the association between ASM% and severity of NAFLD histological features.
We enrolled 401 Chinese male with biopsy-proven NAFLD. Using a bioelectrical-impedance body composition analyzer (BIA, Inbody 720, Japan Inc., Tokyo), we calculated the ASM% as the percentage of total appendicular skeletal muscle mass (ASM, kg)/total body mass (kg) × 100.
Compared to those with high ASM%, patients with low ASM% (≤ 30.6, i.e., the median value of distribution of the whole sample) had a greater severity of individual histological features of NAFLD. These patients also had a higher risk of severe steatosis and non-alcoholic steatohepatitis (NASH) (adjusted-odds ratio [OR] 2.34, 95% CI 1.39-3.93, and adjusted-OR 2.22, 95% CI 1.30-3.77) even after adjusting for age, body mass index, diabetes, and serum creatinine levels. Carriage of the G allele of PNPLA3 rs738409 plus low ASM% was associated with a higher risk of severe steatosis and presence of liver fibrosis (OR 3.02, 95% CI 1.46-6.26, p = 0.003 and OR 2.18, 95% CI 1.03-4.60, p = 0.041 respectively), and there was a non-significant but borderline increased risk of NASH (OR 2.00, 95% CI 0.98-4.06, p = 0.056).
Low ASM% and the presence of a G allele within PNPLA3 rs738409 is associated with more severe histological features of NAFLD.
背景/研究目的:虽然低骨骼肌量与非酒精性脂肪性肝病(NAFLD)有关,但目前尚不确定体重调整后的四肢骨骼肌(ASM%)、NAFLD 组织学特征的严重程度与载脂蛋白样磷脂酶结构域包含 3(PNPLA3)rs738409 多态性之间是否存在关联。我们的目的是检验 PNPLA3 rs738409 变体是否可能影响 ASM%与 NAFLD 组织学特征严重程度之间的关联。
我们招募了 401 名经活检证实患有 NAFLD 的中国男性。使用生物电阻抗体成分分析仪(BIA,Inbody 720,日本 Inc.,东京),我们将 ASM%计算为四肢骨骼肌总质量(ASM,kg)/总体重(kg)×100%。
与 ASM%高的患者相比,ASM%低(≤30.6,即整个样本分布的中位数)的患者 NAFLD 的个别组织学特征更严重。这些患者发生严重脂肪变性和非酒精性脂肪性肝炎(NASH)的风险也更高(校正优势比[OR]2.34,95%可信区间[CI]1.39-3.93,和校正 OR 2.22,95% CI 1.30-3.77),即使在调整年龄、体重指数、糖尿病和血清肌酐水平后也是如此。PNPLA3 rs738409 的 G 等位基因携带加上低 ASM%与严重脂肪变性和肝纤维化的存在相关(OR 3.02,95% CI 1.46-6.26,p=0.003 和 OR 2.18,95% CI 1.03-4.60,p=0.041),并且 NASH 的风险有非显著但边缘增加的趋势(OR 2.00,95% CI 0.98-4.06,p=0.056)。
低 ASM%和 PNPLA3 rs738409 中的 G 等位基因的存在与更严重的 NAFLD 组织学特征相关。